Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Respiratory Distress Syndrome Secondary to Covid-19”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Not applicableUnknownNCT04586114
What this trial is testing

Effect of Corticosteroid Treatment on Prognosis in ARDS Secondary to Covid-19

Who this might be right for
Acute Respiratory Distress Syndrome Secondary to Covid-19
Central Hospital, Nancy, France 200
Early research (Phase 1)Study completedNCT05220605
What this trial is testing

Nebulised BromAc in Healthy Volunteers

Who this might be right for
COVID-19 PneumoniaBromelains Adverse ReactionAcetylcysteine Adverse Reaction+2 more
Mucpharm Pty Ltd 12
Testing effectiveness (Phase 2)Study completedNCT04351243
What this trial is testing

Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)

Who this might be right for
COVID-19
Kinevant Sciences GmbH 227
Large-scale testing (Phase 3)Ended earlyNCT04355364
What this trial is testing

Efficacy and Safety of aerosolizedDornase Alfa Administration in Patients With COVID19 Induced ARDS (COVIDORNASE)

Who this might be right for
COVID-19Acute Respiratory Distress Syndrome
Fondation Ophtalmologique Adolphe de Rothschild 77
Not applicableStudy completedNCT04404426
What this trial is testing

CACOLAC : Citrulline Administration in the Hospital Patient in Intensive Care for COVID-19 Acute Respiratory Distress Syndrome

Who this might be right for
ARDS Secondary to COVID-19 Pneumonia
Rennes University Hospital 33
Testing effectiveness (Phase 2)Study completedNCT04390139
What this trial is testing

Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19

Who this might be right for
COVID-19SARS-CoV 2Adult Respiratory Distress Syndrome
Banc de Sang i Teixits 26
Testing effectiveness (Phase 2)UnknownNCT05258682
What this trial is testing

Safety of Nebulized Combination Therapy BromAc® in COVID-19 Respiratory Disease

Who this might be right for
COVID-19 PneumoniaCOVID-19Ventilator Associated Pneumonia+1 more
Mucpharm Pty Ltd 30
Not applicableUnknownNCT05890560
What this trial is testing

Two-year Efficacy of Three Exercise Rehabilitation Strategies on Dyspnea in Patients Who Presented With Secondary Respiratory Distress Syndrome Secondary to Severe COVID-19 Pneumonia

Who this might be right for
DyspneaCOVID-19
Fondation Hôpital Saint-Joseph 120
Large-scale testing (Phase 3)Study completedNCT04979884
What this trial is testing

Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University Hospital

Who this might be right for
COVID-19 Acute Respiratory Distress SyndromeCytokine Release SyndromePulmonary Fibrosis
Alexandria University 66
Not applicableUnknownNCT04332913
What this trial is testing

Efficacy and Safety of Tocilizumab in the Treatment of SARS-Cov-2 Related Pneumonia

Who this might be right for
COVID-19 Pneumonia
University of L'Aquila 30
Not applicableStudy completedNCT04569266
What this trial is testing

Effectiveness of an Exercise Re-training Program on Dyspnea in Patients After Acute Respiratory Distress Syndrome Secondary to Severe COVID-19 Pneumonia in Post-ICU

Who this might be right for
Dyspnea
Fondation Hôpital Saint-Joseph 63
Not applicableUnknownNCT04556864
What this trial is testing

Hemodynamic Impact on Critical Care Patients With Lung Damage Secondary to COVID-19

Who this might be right for
Covid19Hemodynamic InstabilityARDS, Human
Juan Victor Lorente 67